Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.9388 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von James Libecco und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Skin Cream, Cortodoxone, Dermatologic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Libecco, J., Eichenfield, L. F., Hebert, A. A., Gold, L. S., Cartwright, M., Moro, L., Sane, S., Lionnet, L., Shukla, D., Mazzetti, A., Squittieri, N., & Kyeremateng, K. (2026). Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9388
Vancouver
Libecco J, Eichenfield LF, Hebert AA, Gold LS, Cartwright M, Moro L, et al. Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9388
BibTeX
@article{Libecco2026,
author = {Libecco, James and Eichenfield, Lawrence F and Hebert, Adelaide A and Gold, Linda Stein and Cartwright, Martina and Moro, Luigi and Sane, Shrivallabh and Lionnet, Leonard and Shukla, Dhara and Mazzetti, Alessandro and Squittieri, Nicholas and Kyeremateng, Kizito},
title = {Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.9388}
}
EUVIMED